The latest uptick in S&P futures aligns with broader global equity optimism as emerging markets rally. Investors appear confident in U.S. corporate margins holding steady despite input cost pressures. Now, it’s worth noting Stock Advisor’s total average return is 1,058 % — a market-crushing outperformance compared to 191% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor . "Given the potential upside to JNJ's Pharma business, lower Pharma tariff and pricing risk, and investor confidence that JNJ can grow through the Stelara LOE, we could see JNJ's valuation move higher," analyst Larry Biegelsen said Friday in a note to clients. Analysts believe corporate buyback programs are quietly underpinning the rally.